High-dose antiandrogen tied to intracranial meningioma: study

The cumulative dose with prolonged usage is what matters, researchers say
Reuters Health Staff writer

Women and girls who take high-dose cyproterone acetate for long periods of time are at increased risk of intracranial meningiomas compared with those who have more limited exposure to the progestogen, a study suggests.

French researchers examined data on more than 250,000 girls and women aged between seven and 70 who initiated cyproterone acetate therapy between 2007 and 2014.